about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesFlow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemiaAutomated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotypingMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesNew criteria for response assessment: role of minimal residual disease in multiple myelomaEfficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseGenetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.Generation of flow cytometry data files with a potentially infinite number of dimensions.CD3G gene defects in familial autoimmune thyroiditis.Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies.T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.Analysing the developing lymphocyte system of neonates and infants.Differentiation stage of myeloma plasma cells: biological and clinical significance.Immunophenotypical detection of minimal residual disease in acute leukemia.Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma.Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.The MLL recombinome of acute leukemias in 2013.Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.Clonality analysis for antigen receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells.Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferationsPID comes full circle: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders.Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive IgsReplication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansionSplit-signal FISH for detection of chromosome aberrations.Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia.The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.
P50
Q24604581-46604DA9-CD8E-4949-9615-0C3D67D783FFQ24604850-7FBCB647-73A5-4965-B9E5-3DC0B5CD6BB1Q24628943-B25ECCBB-90BD-4FEB-86DF-FA64FDDE4E8AQ26828511-D9BC32C6-8A8D-4471-B67E-F1F4ED952DE1Q27027512-B87ADC96-761D-494E-B6A2-9D3C1689C468Q28204295-01F53C37-480B-4E26-BA97-5FA9559E7610Q30157267-F1CDF41C-AADF-42F0-9BA4-A4725EBCFF15Q30938779-61CD8BC7-D763-4A96-B1B3-6E442B3CC9ECQ31012437-962A0F74-9582-4C2D-981B-F5B516A27742Q31099184-CBDC7D35-2594-4B2A-BFA7-99212FE3AB46Q31162718-0A717792-AB33-4100-AE16-71DD39C20907Q33415803-1B4B52D7-3497-4AEB-849F-CC20A7490CC5Q33502015-1AC31C0A-D5CA-49E0-A365-94AF07CB9A15Q33702157-321CD9A7-312F-4519-8599-088B80C93B88Q33710217-B78A6AA1-9478-4374-9672-41739855491FQ33712516-867FA421-825B-432D-B92B-9BD1E1243463Q33816575-6B7AA477-2BC4-4B21-B7C9-ECC4C3B7B77DQ34156865-00790860-26AC-4D54-9DC2-E7D74F73ADE8Q34211015-1AE6E773-7EEE-4869-9FA8-0DC728997168Q34281162-82D219C3-0040-40AE-9441-E2F98EA96A15Q34387780-F74A9401-E2F5-4C4A-B6AB-7600907DA8EDQ34422631-F6CEC660-8A95-4D85-9386-E1B859A57CC1Q34623046-291EC2D0-0959-4509-91FE-E76E02935277Q34651113-04C136E3-3B98-47B9-B478-B8C036FA02ABQ34977308-C6D05635-C33F-421B-A50A-B1CAF977599FQ35122249-7F90ED8E-1DC1-4A7C-A8B6-E69386B73855Q35134983-F3190E61-C828-4E16-A891-375D8427EEA4Q35161219-EA675F00-E999-46B1-AAA7-34423AF963A8Q35166863-C1448EEF-775D-48BA-AE74-887999382609Q35182709-04646DCF-2268-4CF1-BC1F-ED63423B5C50Q35561038-9A8BE899-3618-4877-8ABD-AA7117CCAC62Q35606345-23BE01BA-1077-48DF-926C-50474FAF5B42Q35810860-57663610-BA42-461B-91AF-4968B6815BEEQ35855505-4287BE73-D94D-4AE4-8C4D-9598D4DD4CF4Q35928316-80939F93-C565-430B-9044-82B04218CCE8Q36129466-65C05FE9-2B7B-40E7-91F0-1DD9C95E361DQ36267196-3F6FCFE9-15F4-443C-BA50-A54E6556EA41Q36269955-66F49576-3AF4-45A7-9469-7E93236BE54EQ36346086-46057623-F11C-4998-A76D-2ED7CA966D5EQ36402422-1C04BA4B-C4E6-458B-B608-C5C8EC0C06F6
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3650-7087
@en
name
Jacques Van Dongen
@ast
Jacques Van Dongen
@en
Jacques Van Dongen
@es
Jacques Van Dongen
@nl
type
label
Jacques Van Dongen
@ast
Jacques Van Dongen
@en
Jacques Van Dongen
@es
Jacques Van Dongen
@nl
prefLabel
Jacques Van Dongen
@ast
Jacques Van Dongen
@en
Jacques Van Dongen
@es
Jacques Van Dongen
@nl
P106
P1153
7201765517
P21
P31
P496
0000-0002-3650-7087